Graft-versus-host disease in children.
With the continued use of bone marrow transplantation in the treatment of malignancies, immunodeficiencies, and some metabolic diseases in children, it remains important for the dermatologist to be aware of the clinical and diagnostic features, and pathophysiology of Graft vs. Host disease. Specifically, the dermatologist should keep in mind that the skin is a primary site for involvement in this process. Recognition of the spectrum of cutaneous disease, its methods of laboratory diagnosis, and treatment should be known to those physicians caring for patients undergoing this type of therapy. A brief review of these and other aspects of Graft vs. Host disease is presented in this report.
Dinulos
J G
JG
East Virginia Medical School, Norfolk, USA.
Levy
M L
ML
D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D006086:Graft vs Host Disease / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D006801:Humans; D012871:Skin Diseases / Q000175:diagnosis* / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology